Properties (59)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
biotechnology company
|
| gptkbp:acquisition |
BioConnection
|
| gptkbp:budget |
published annually
|
| gptkbp:businessModel |
focused on rare diseases
actively seeking partnerships |
| gptkbp:CEO |
gptkb:Sijmen_de_Vries
|
| gptkbp:clinicalTrials |
gptkb:hereditary_angioedema
Europe Phase II diverse demographics multiple phases ongoing studies Phase III trials specific diseases published in journals secured funding |
| gptkbp:collaborations |
gptkb:University_of_Amsterdam
|
| gptkbp:community_service |
available for patients
|
| gptkbp:communityEngagement |
active in patient advocacy
|
| gptkbp:employees |
~100
|
| gptkbp:financialPerformance |
growing revenue
strong portfolio |
| gptkbp:financials |
available to shareholders
|
| gptkbp:focus |
rare diseases
|
| gptkbp:founded |
1985
|
| gptkbp:founder |
Berthe_de_Vries
|
| gptkbp:globalPresence |
operates internationally
|
| gptkbp:hasPrograms |
composed of experts
|
| gptkbp:headquarters |
gptkb:Leiden,_Netherlands
|
| gptkbp:historicalResearch |
with academic institutions
|
| https://www.w3.org/2000/01/rdf-schema#label |
Pharming Group
|
| gptkbp:industry |
biotechnology
|
| gptkbp:investmentFocus |
Institutional investors
in innovative therapies |
| gptkbp:leadership |
experienced management team
|
| gptkbp:market |
global market
in various countries €500 million (2021) |
| gptkbp:marketSegment |
focused on niche markets
|
| gptkbp:partnerships |
various pharmaceutical companies
Sobi |
| gptkbp:patentCitation |
multiple patents in biotechnology
|
| gptkbp:productLine |
diverse pipeline
|
| gptkbp:products |
gptkb:Ruconest
|
| gptkbp:regulatoryCompliance |
adheres to regulations
FDA_approval_for_Ruconest |
| gptkbp:research_areas |
immunology
|
| gptkbp:researchAndDevelopment |
significant investment
|
| gptkbp:researchFocus |
recombinant proteins
|
| gptkbp:researchInterest |
with biotech firms
received from government frequently published |
| gptkbp:revenue |
€30 million (2020)
|
| gptkbp:stockSymbol |
PHARM
|
| gptkbp:strategicGoals |
expand product offerings
|
| gptkbp:sustainabilityInitiatives |
environmental responsibility
|
| gptkbp:tradedOn |
Euronext Amsterdam
|
| gptkbp:type |
public company
|
| gptkbp:website |
www.pharming.com
|